Keohane Sean D 4
4 · Chemours Co · Filed May 8, 2026
Research Summary
AI-generated summary of this filing
Chemours (CC) Director Sean Keohane Receives Award of 7,182 Units
What Happened
Sean D. Keohane, a director of Chemours Co. (CC), was granted 7,182 stock units on 2026-05-06. The units were reported as an award/acquisition (code A) at $0.00 per unit (total reported cash value $0) — a non-cash director compensation award rather than a market purchase. Footnotes indicate these are deferred stock units (including dividend equivalent units) that will convert one-for-one into Chemours common stock upon separation from board service.
Key Details
- Transaction date: 2026-05-06; reported in a Form 4 filed 2026-05-08 (two days after the transaction; appears timely under Form 4 rules).
- Price: $0.00 per unit; reported cash value $0 (non-cash award).
- Shares/units granted: 7,182 deferred stock units.
- Shares owned after transaction: Not specified in the provided filing details.
- Footnotes: F1 — units convert one-for-one to common stock upon separation from board service. F2 — grant includes deferred stock units and dividend equivalent units.
- Transaction type: Award/Grant (compensation), not a purchase or sale.
Context
Director awards of deferred stock units are common as part of board compensation and do not represent an open-market buy or sell. Because these units convert to actual shares later (per F1) and include dividend equivalents (F2), they do not provide an immediate cash or tradable-share signal about the director’s views on the stock.
Insider Transaction Report
- Award
Common Stock
[F1][F2]2026-05-06+7,182→ 72,555.178 total
Footnotes (2)
- [F1]Represents stock units that will convert one-for-one to Chemours common stock upon separation from service on the Board.
- [F2]Includes deferred stock units and dividend equivalent units.